The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Sell(S) | 3.5M | $0.02 | $70K |
| Jan 31, 2023 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Sell(S) | 1.5M | $0.01 | $15K |
| Jan 10, 2023 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Sell(S) | 6.3M | $0.01 | $63K |
| Oct 24, 2022 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Sell(S) | 3.0M | $0.04 | $120K |
| Sep 26, 2022 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Sell(S) | 1.3M | $0.02 | $25K |
| Sep 12, 2022 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Sell(S) | 7.0M | $0.02 | $140K |
| Jul 20, 2022 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Other(J) | 333.2M | — | $0 |
| Jul 20, 2022 | Nika Pharmaceuticals, Inc | Secretary, Director, 10% Owner | Other(J) | 145.0M | — | $0 |
| Apr 29, 2022 | Nika Pharmaceuticals, Inc | Secretary, Director, 10% Owner | Other(J) | 5.0M | $50,000.00 | $250.0B |
| Apr 13, 2022 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Other(J) | 10.0M | $3,000,000.00 | $30.0T |
| Apr 13, 2022 | Nika Pharmaceuticals, Inc | President, CEO, CFO, Director, 10% Owner | Buy(P) | 11.5M | $0.01 | $115K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).